Aquilo Capital Management’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-367,214
| Closed | -$2.53M | – | 14 |
|
|
2024
Q4 | $2.53M | Buy |
367,214
+50,000
| +16% | +$344K | 3.81% | 9 |
|
|
2024
Q3 | $5.77M | Sell |
317,214
-183,000
| -37% | -$3.33M | 4.37% | 7 |
|
|
2024
Q2 | $9.5M | Sell |
500,214
-74,000
| -13% | -$1.41M | 9.16% | 6 |
|
|
2024
Q1 | $12.4M | Sell |
574,214
-469,070
| -45% | -$10.1M | 9.3% | 6 |
|
|
2023
Q4 | $18.1M | Sell |
1,043,284
-268,949
| -20% | -$4.67M | 11.29% | 5 |
|
|
2023
Q3 | $12.9M | Hold |
1,312,233
| – | – | 11.68% | 4 |
|
|
2023
Q2 | $7.22M | Hold |
1,312,233
| – | – | 4% | 7 |
|
|
2023
Q1 | $8.14M | Buy |
1,312,233
+28,100
| +2% | +$174K | 3.37% | 10 |
|
|
2022
Q4 | $19.6M | Buy |
1,284,133
+21,008
| +2% | +$320K | 7.36% | 6 |
|
|
2022
Q3 | $12.7M | Buy |
+1,263,125
| New | +$12.7M | 4.57% | 8 |
|